On a disclosed basis, annual revenue rose from KRW 269.4 billion in 2024 to KRW 287.3 billion in 2025, up 6.6%. Over the same period operating profit moved from KRW 92.8 billion to KRW 92.5 billion, down 0.3%, and the operating margin fell from 34.4% to 32.2%.
Net profit attributable to controlling shareholders rose 18.6%, from KRW 68.7 billion to KRW 81.4 billion. Net income including non-controlling interests moved in the same direction, from KRW 68.7 billion to KRW 81.4 billion.
Press coverage attributes the gap between the flat operating profit and the higher net income partly to one-off costs tied to the IPO preparation, and says that excluding them profitability held near the prior year's level. Operating cash flow eased from KRW 83 billion to KRW 81.6 billion.
At the end of 2025, total liabilities were KRW 47.3 billion, the debt ratio fell from 9.4% to 6.0%, and total equity of KRW 794.4 billion was entirely attributable to controlling shareholders.
Quarterly revenue bottomed at KRW 72.1 billion in Q4 2025, then rose to KRW 72.1 billion in Q1 2026, KRW 76.1 billion in Q2 and KRW 76.8 billion in Q3.
Operating profit was KRW 23.7 billion in Q4 2025, KRW 25.1 billion in Q1 2026 (up 6.1% quarter on quarter), KRW 27.6 billion in Q2 (up 10.0%) and KRW 27.1 billion in Q3 (down 2.0%). Annual R&D spending was KRW 17.7 billion in 2025, or 6.2% of sales, and Q1 2026 R&D was KRW 3.7 billion, or 5.2% of sales.